Brass EP - Search Results

1

Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal disease.

Sietsema KE, Amato A, Adler SG, Brass EP. Sietsema KE, et al. Among authors: brass ep. Kidney Int. 2004 Feb;65(2):719-24. doi: 10.1111/j.1523-1755.2004.00411.x. Kidney Int. 2004. PMID: 14717947

2

Potential biomarkers of muscle injury after eccentric exercise.

Sietsema KE, Meng F, Yates NA, Hendrickson RC, Liaw A, Song Q, Brass EP, Ulrich RG. Sietsema KE, et al. Among authors: brass ep. Biomarkers. 2010 May;15(3):249-58. doi: 10.3109/13547500903502802. Biomarkers. 2010. PMID: 20028270

3

Patient and hospital-level characteristics associated with the use of do-not-resuscitate orders in patients hospitalized for sepsis.

Chang DW, Brass EP. Chang DW, et al. Among authors: brass ep. J Gen Intern Med. 2014 Sep;29(9):1256-62. doi: 10.1007/s11606-014-2906-x. Epub 2014 Jun 14. J Gen Intern Med. 2014. PMID: 24928264 Free PMC article.

4

Association of clinical attributes and treadmill walking performance in patients with claudication due to peripheral artery disease.

Brass EP, Cooper LT, Hanson P, Hiatt WR. Brass EP, et al. J Vasc Surg. 2013 Aug;58(2):396-403. doi: 10.1016/j.jvs.2012.12.077. Epub 2013 May 16. J Vasc Surg. 2013. PMID: 23684414

5

A systematic review and meta-analysis of propionyl-L-carnitine effects on exercise performance in patients with claudication.

Brass EP, Koster D, Hiatt WR, Amato A. Brass EP, et al. Vasc Med. 2013 Feb;18(1):3-12. doi: 10.1177/1358863X12467491. Epub 2013 Jan 15. Vasc Med. 2013. PMID: 23321261 Review.

6

Risk factors for mortality in patients with mucormycosis.

Spellberg B, Kontoyiannis DP, Fredricks D, Morris MI, Perfect JR, Chin-Hong PV, Ibrahim AS, Brass EP. Spellberg B, et al. Among authors: brass ep. Med Mycol. 2012 Aug;50(6):611-8. doi: 10.3109/13693786.2012.669502. Epub 2012 Mar 21. Med Mycol. 2012. PMID: 22435877 Free PMC article. Clinical Trial.

7

Differential management of cardiovascular disease in ESRD by nephrologists and cardiologists.

Martirosyan HA, Brass EP, Mehrotra R, Adler SG; Cardio-Renal Responder Group and the Validation Cohort. Martirosyan HA, et al. Among authors: brass ep. Am J Kidney Dis. 2004 Aug;44(2):309-21. doi: 10.1053/j.ajkd.2004.04.036. Am J Kidney Dis. 2004. PMID: 15264190

8

The novel phosphodiesterase inhibitor NM-702 improves claudication-limited exercise performance in patients with peripheral arterial disease.

Brass EP, Anthony R, Cobb FR, Koda I, Jiao J, Hiatt WR. Brass EP, et al. J Am Coll Cardiol. 2006 Dec 19;48(12):2539-45. doi: 10.1016/j.jacc.2006.07.064. Epub 2006 Nov 28. J Am Coll Cardiol. 2006. PMID: 17174195 Clinical Trial.

9

Clinical and demographic predictors of exercise capacity in end-stage renal disease.

Sietsema KE, Hiatt WR, Esler A, Adler S, Amato A, Brass EP. Sietsema KE, et al. Among authors: brass ep. Am J Kidney Dis. 2002 Jan;39(1):76-85. doi: 10.1053/ajkd.2002.29884. Am J Kidney Dis. 2002. PMID: 11774105

10

Peripheral arterial disease is not associated with an increased prevalence of intradialytic cramps in patients on maintenance hemodialysis.

Brass EP, Adler S, Sietsema KE, Amato A, Esler A, Hiatt WR. Brass EP, et al. Am J Nephrol. 2002 Sep-Dec;22(5-6):491-6. doi: 10.1159/000065285. Am J Nephrol. 2002. PMID: 12381949

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results